pISSN 1976-2283
eISSN 2005-1212

Cited by CrossRef (202)

  1. Mitchell R. McGill, Benjamin L. Woolbright, James L. Weemhoff, Hartmut Jaeschke. Biomarkers in Liver Disease. .
    https://doi.org/10.1007/978-94-007-7675-3_5
  2. Weiqi Xu, Xiang Zhang, Jian-lin Wu, Li Fu, Ken Liu, Dabin Liu, George Gong Chen, Paul Bo-san Lai, Nathalie Wong, Jun Yu. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress. Journal of Hepatology 2017;67:310
    https://doi.org/10.1016/j.jhep.2017.03.017
  3. Cuiying Xiao, Rui-Hong Wang, Tyler J. Lahusen, Ogyi Park, Adeline Bertola, Takashi Maruyama, Della Reynolds, Qiang Chen, Xiaoling Xu, Howard A. Young, Wan-Jun Chen, Bin Gao, Chu-Xia Deng. Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling inSirt6Mutant Mice. J. Biol. Chem. 2012;287:41903
    https://doi.org/10.1074/jbc.M112.415182
  4. Chanbin Lee, Jieun Kim, Sihyung Wang, Sumi Sung, Namgyu Kim, Hyun-Hee Lee, Young-Su Seo, Youngmi Jung. Hepatoprotective Effect of Kombucha Tea in Rodent Model of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. IJMS 2019;20:2369
    https://doi.org/10.3390/ijms20092369
  5. S. Di Mauro, M. Ragusa, F. Urbano, A. Filippello, A. Di Pino, A. Scamporrino, A. Pulvirenti, A. Ferro, A.M. Rabuazzo, M. Purrello, F. Purrello, S. Piro. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications. Nutrition, Metabolism and Cardiovascular Diseases 2016;26:1129
    https://doi.org/10.1016/j.numecd.2016.08.004
  6. Rebekka Pohl, Lisa Rein-Fischboeck, Elisabeth M. Meier, Kristina Eisinger, Sabrina Krautbauer, Christa Buechler. Resolvin E1 and chemerin C15 peptide do not improve rodent non-alcoholic steatohepatitis. Experimental and Molecular Pathology 2015;98:295
    https://doi.org/10.1016/j.yexmp.2015.02.005
  7. Fahrettin Haczeyni, Vanessa Barn, Auvro R. Mridha, Matthew M. Yeh, Emma Estevez, Mark A. Febbraio, Christopher J. Nolan, Kim S. Bell-Anderson, Narci C. Teoh, Geoffrey C. Farrell. Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. Obesity 2015;23:1845
    https://doi.org/10.1002/oby.21170
  8. Beth Conlon, Jeannette Beasley, Karin Aebersold, Sunil Jhangiani, Judith Wylie-Rosett. Nutritional Management of Insulin Resistance in Nonalcoholic Fatty Liver Disease (NAFLD). Nutrients 2013;5:4093
    https://doi.org/10.3390/nu5104093
  9. Matthew T. Goodus, Dana M. McTigue. Hepatic dysfunction after spinal cord injury: A vicious cycle of central and peripheral pathology?. Experimental Neurology 2020;325:113160
    https://doi.org/10.1016/j.expneurol.2019.113160
  10. Sarit Anavi, Michal Eisenberg-Bord, Michal Hahn-Obercyger, Olga Genin, Mark Pines, Oren Tirosh. The role of iNOS in cholesterol-induced liver fibrosis. Lab Invest 2015;95:914
    https://doi.org/10.1038/labinvest.2015.67
  11. Suvarthi Das, Ashutosh Kumar, Ratanesh Kumar Seth, Erik J. Tokar, Maria B. Kadiiska, Michael P. Waalkes, Ronald P. Mason, Saurabh Chatterjee. Proinflammatory adipokine leptin mediates disinfection byproduct bromodichloromethane-induced early steatohepatitic injury in obesity. Toxicology and Applied Pharmacology 2013;269:297
    https://doi.org/10.1016/j.taap.2013.02.003
  12. Reza Meshkani, Sanaz Vakili. Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications. Clinica Chimica Acta 2016;462:77
    https://doi.org/10.1016/j.cca.2016.08.015
  13. Simon Ducheix, Maria Carmela Vegliante, Gaetano Villani, Nicola Napoli, Carlo Sabbà, Antonio Moschetta. Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β. Cell. Mol. Life Sci. 2016;73:3809
    https://doi.org/10.1007/s00018-016-2331-x
  14. Yuan Tian, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Alfred Sze-Lok Cheng. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Seminars in Cancer Biology 2013;23:471
    https://doi.org/10.1016/j.semcancer.2013.08.010
  15. Makoto Usami. Gut microbiota and host metabolism in liver cirrhosis. WJG 2015;21:11597
    https://doi.org/10.3748/wjg.v21.i41.11597
  16. Rejina Afrin, Somasundaram Arumugam, Azizur Rahman, Mir Imam Ibne Wahed, Vengadeshprabhu Karuppagounder, Meilei Harima, Hiroshi Suzuki, Shizuka Miyashita, Kenji Suzuki, Hiroyuki Yoneyama, Kazuyuki Ueno, Kenichi Watanabe. Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-κB translocation. International Immunopharmacology 2017;44:174
    https://doi.org/10.1016/j.intimp.2017.01.016
  17. Maria Boddi, Roberto Tarquini, Marco Chiostri, Fabio Marra, Serafina Valente, Cristina Giglioli, Gian F. Gensini, Rosanna Abbate. Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes. Eur J Clin Invest 2013;43:429
    https://doi.org/10.1111/eci.12065
  18. Yvette Simon, Sonja M Kessler, Katja Gemperlein, Rainer M Bohle, Rolf Müller, Johannes Haybaeck, Alexandra K Kiemer. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. WJG 2014;20:17839
    https://doi.org/10.3748/wjg.v20.i47.17839
  19. Michael Karin. New insights into the pathogenesis and treatment of non-viral hepatocellular carcinoma: a balancing act between immunosuppression and immunosurveillance. 2018;1:21
    https://doi.org/10.1093/pcmedi/pby005
  20. Shahinul Alam. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. WJH 2013;5:281
    https://doi.org/10.4254/wjh.v5.i5.281
  21. P. J. Meakin, S. Chowdhry, R. S. Sharma, F. B. Ashford, S. V. Walsh, R. J. McCrimmon, A. T. Dinkova-Kostova, J. F. Dillon, J. D. Hayes, M. L. J. Ashford. Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance. Molecular and Cellular Biology 2014;34:3305
    https://doi.org/10.1128/MCB.00677-14
  22. Emmanuel Mas, Marie Danjoux, Virginie Garcia, Stéphane Carpentier, Bruno Ségui, Thierry Levade. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. Digestive and Liver Disease 2013;45:147
    https://doi.org/10.1016/j.dld.2012.09.002
  23. Guy Bower, Tania Toma, Leanne Harling, Long R Jiao, Evangelos Efthimiou, Ara Darzi, Thanos Athanasiou, Hutan Ashrafian. Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology. OBES SURG 2015;25:2280
    https://doi.org/10.1007/s11695-015-1691-x
  24. Yuan Tian, Myth Mok, Pengyuan Yang, Alfred Cheng. Epigenetic Activation of Wnt/β-Catenin Signaling in NAFLD-Associated Hepatocarcinogenesis. Cancers 2016;8:76
    https://doi.org/10.3390/cancers8080076
  25. B. Fromenty. Fat accretion in a subpopulation of hepatocytes as a strategy to protect the whole liver against oxidative stress and lipotoxicity. Clinics and Research in Hepatology and Gastroenterology 2013;37:553
    https://doi.org/10.1016/j.clinre.2013.08.005
  26. Ji-Young Cha, Da-Hyun Kim, Kyung-Hee Chun. The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Lab Anim Res 2018;34:133
    https://doi.org/10.5625/lar.2018.34.4.133
  27. Xiang Zhang, Lina Fan, Jianfeng Wu, Hongzhi Xu, Wing Yan Leung, Kaili Fu, Jingtong Wu, Ken Liu, Kwan Man, Xiaoyong Yang, Jiahuai Han, Jianlin Ren, Jun Yu. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization. Journal of Hepatology 2019;71:163
    https://doi.org/10.1016/j.jhep.2019.03.014
  28. E. Sabath, A. Báez-Ruiz, R. M. Buijs. Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization. Obes Rev 2015;16:871
    https://doi.org/10.1111/obr.12308
  29. Chen-Lu Wu, Shui-Ping Zhao, Bi-Lian Yu. Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line. Lipids Health Dis 2013;12:186
    https://doi.org/10.1186/1476-511X-12-186
  30. Naoki Tanaka, Shogo Takahashi, Zhong-Ze Fang, Tsutomu Matsubara, Kristopher W. Krausz, Aijuan Qu, Frank J. Gonzalez. Role of white adipose lipolysis in the development of NASH induced by methionine- and choline-deficient diet. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014;1841:1596
    https://doi.org/10.1016/j.bbalip.2014.08.015
  31. J. Michael Estep, Zachary Goodman, Haveesh Sharma, Elana Younossi, Hazem Elarainy, Ancha Baranova, Zobair Younossi. Adipocytokine expression associated with miRNA regulation and diagnosis of NASH in obese patients with NAFLD. Liver Int 2015;35:1367
    https://doi.org/10.1111/liv.12555
  32. Federica Del Chierico, Pamela Vernocchi, Bruno Dallapiccola, Lorenza Putignani. Mediterranean Diet and Health: Food Effects on Gut Microbiota and Disease Control. IJMS 2014;15:11678
    https://doi.org/10.3390/ijms150711678
  33. David Ipsen, Pernille Tveden-Nyborg, Jens Lykkesfeldt. Does Vitamin C Deficiency Promote Fatty Liver Disease Development?. Nutrients 2014;6:5473
    https://doi.org/10.3390/nu6125473
  34. Gülen Arslan Lied, Odd Helge Gilja, Trygve Hausken. Har silibinin en plass i behandlingen av leversykdommer?. Tidsskriftet 2014;134:392
    https://doi.org/10.4045/tidsskr.13.1531
  35. Tang-you Mao, Rui Shi, Wei-han Zhao, Yi Guo, Kang-li Gao, Chen Chen, Tian-hong Xie, Jun-xiang Li. Qingchang Wenzhong Decoction Ameliorates Dextran Sulphate Sodium-Induced Ulcerative Colitis in Rats by Downregulating the IP10/CXCR3 Axis-Mediated Inflammatory Response. Evidence-Based Complementary and Alternative Medicine 2016;2016:1
    https://doi.org/10.1155/2016/4312538
  36. Bing Xu, Mingzuo Jiang, Yi Chu, Weijie Wang, Di Chen, Xiaowei Li, Zhao Zhang, Di Zhang, Daiming Fan, Yongzhan Nie, Feng Shao, Kaichun Wu, Jie Liang. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Journal of Hepatology 2018;68:773
    https://doi.org/10.1016/j.jhep.2017.11.040
  37. Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba. Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial. Therap Adv Gastroenterol 2016;9:152
    https://doi.org/10.1177/1756283X15621232
  38. Lori Edwards, Ian R. Wanless. Mechanisms of liver involvement in systemic disease. Best Practice & Research Clinical Gastroenterology 2013;27:471
    https://doi.org/10.1016/j.bpg.2013.08.002
  39. Bing-Hang Li, Fang-Ping He, Xin Yang, Yuan-Wen Chen, Jian-Gao Fan. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Translational Research 2017;180:103
    https://doi.org/10.1016/j.trsl.2016.08.006
  40. M.G. Fernandez-Barrena, C.L. Pin. Chromatin Signaling and Diseases. 2017.
    https://doi.org/10.1016/B978-0-12-802389-1.00020-4
  41. Ratanesh Kumar Seth, Ashutosh Kumar, Suvarthi Das, Maria B. Kadiiska, Gregory Michelotti, Anna Mae Diehl, Saurabh Chatterjee. Environmental Toxin–Linked Nonalcoholic Steatohepatitis and Hepatic Metabolic Reprogramming in Obese Mice. 2013;134:291
    https://doi.org/10.1093/toxsci/kft104
  42. Claudia Marcela Vanegas Ramírez, Camilo Restrepo R, Natalia Vargas Grisales, Andrés Eduardo Marín Castro, Lina María Martínez Sánchez, Carlos Enrique Yepes Delgado, Juan Carlos Restrepo Gutiérrez. Caracterización de pacientes con enfermedad del hígado graso no alcohólica en un hospital de alta complejidad, Colombia 2013. Rev Colomb Gastroenterol 2014;29:342
    https://doi.org/10.22516/25007440.421
  43. Anabel García-Heredia, Elizabeth Kensicki, Robert P. Mohney, Anna Rull, Iris Triguero, Judit Marsillach, Carmen Tormos, Bharti Mackness, Michael Mackness, Diana M. Shih, Juan Pedro-Botet, Jorge Joven, Guillermo Sáez, Jordi Camps. Paraoxonase-1 Deficiency Is Associated with Severe Liver Steatosis in Mice Fed a High-fat High-cholesterol Diet: A Metabolomic Approach. J. Proteome Res. 2013;12:1946
    https://doi.org/10.1021/pr400050u
  44. Xianbin Cai, Chongye Fang, Shuhei Hayashi, Shumei Hao, Mingming Zhao, Hiroko Tsutsui, Shuhei Nishiguchi, Jun Sheng. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice. J Gastroenterol 2016;51:819
    https://doi.org/10.1007/s00535-015-1154-0
  45. Priya Handa, Kris V. Kowdley. Dendritic cells in NASH: Friend or foe?. Annals of Hepatology 2013;12:508
    https://doi.org/10.1016/S1665-2681(19)31018-X
  46. Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, Francesca Urbano, Agnese Filippello, Marco Ragusa, Maria T. Di Martino, Francesca Scionti, Stefania Grimaudo, Rosaria M. Pipitone, Graziella Privitera, Antonino Di Pino, Roberto Scicali, Luca Valenti, Paola Dongiovanni, Anna Fracanzani, Agata M. Rabuazzo, Antonio Craxì, Michele Purrello, Francesco Purrello, Salvatore Piro. Serum coding and non‐coding RNAs as biomarkers of NAFLD and fibrosis severity. Liver Int 2019;39:1742
    https://doi.org/10.1111/liv.14167
  47. Ugo Soffientini, Anna-Maria Caridis, Sharron Dolan, Annette Graham. Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2014;1841:1372
    https://doi.org/10.1016/j.bbalip.2014.07.002
  48. Tim Hendrikx, Veerle Bieghs, Sofie M. A. Walenbergh, Patrick J. van Gorp, Fons Verheyen, Mike L. J. Jeurissen, Mandy M. F. Steinbusch, Nathalie Vaes, Christoph J. Binder, Ger H. Koek, Rinke Stienstra, Mihai G. Netea, Marten H. Hofker, Ronit Shiri-Sverdlov, Irving Coy Allen. Macrophage Specific Caspase-1/11 Deficiency Protects against Cholesterol Crystallization and Hepatic Inflammation in Hyperlipidemic Mice. PLoS ONE 2013;8:e78792
    https://doi.org/10.1371/journal.pone.0078792
  49. Elham Karimi-Sales, Sajad Jeddi, Abbas Ebrahimi-Kalan, Mohammad Reza Alipour. trans-Chalcone prevents insulin resistance and hepatic inflammation and also promotes hepatic cholesterol efflux in high-fat diet-fed rats: modulation of miR-34a-, miR-451-, and miR-33a-related pathways. Food Funct. 2018;9:4292
    https://doi.org/10.1039/C8FO00923F
  50. Rebekka Pohl, Elisabeth M. Haberl, Lisa Rein-Fischboeck, Sebastian Zimny, Maximilian Neumann, Charalampos Aslanidis, Doris Schacherer, Sabrina Krautbauer, Kristina Eisinger, Thomas S. Weiss, Christa Buechler. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis. Eur J Clin Invest 2017;47:7
    https://doi.org/10.1111/eci.12695
  51. Nishika Sahini, Jürgen Borlak. Genomics of human fatty liver disease reveal mechanistically linked lipid droplet–associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. Translational Research 2016;177:41
    https://doi.org/10.1016/j.trsl.2016.06.003
  52. Auvro R. Mridha, Fahrettin Haczeyni, Matthew M. Yeh, W. Geoffrey Haigh, George N. Ioannou, Vanessa Barn, Hussam Ajamieh, Leon Adams, Jeffrey M. Hamdorf, Narci C. Teoh, Geoffrey C. Farrell. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival. 2017;131:2145
    https://doi.org/10.1042/CS20160838
  53. Jing Gao, Jiajia Song, Min Du, Xueying Mao. Bovine α-lactalbumin hydrolysates (α-LAH) attenuate high-fat diet induced nonalcoholic fatty liver disease by modulating hepatic lipid metabolism in C57BL/6J mice. Journal of Functional Foods 2019;54:254
    https://doi.org/10.1016/j.jff.2019.01.027
  54. Sara Ashtari. Non-alcohol fatty liver disease in Asia: Prevention and planning. WJH 2015;7:1788
    https://doi.org/10.4254/wjh.v7.i13.1788
  55. Li-ping Han, Chun-jun Li, Bei Sun, Yun Xie, Yue Guan, Ze-jun Ma, Li-ming Chen. Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats. Journal of Diabetes Research 2016;2016:1
    https://doi.org/10.1155/2016/2641248
  56. Hyun Jung Lee. Peroxisome proliferator-activated receptor-delta agonist ameliorated inflammasome activation in nonalcoholic fatty liver disease. WJG 2015;21:12787
    https://doi.org/10.3748/wjg.v21.i45.12787
  57. Ruonan Wu, Geicho Nakatsu, Xiang Zhang, Jun Yu. Pathophysiological mechanisms and therapeutic potentials of macrophages in non-alcoholic steatohepatitis. Expert Opinion on Therapeutic Targets 2016;20:615
    https://doi.org/10.1517/14728222.2016.1125883
  58. Jinhui Li, Teryn N. Sapper, Eunice Mah, Swetha Rudraiah, Kevin E. Schill, Chureeporn Chitchumroonchokchai, Meredith V. Moller, Joshua D. McDonald, Philip R. Rohrer, José E. Manautou, Richard S. Bruno. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. Mol. Nutr. Food Res. 2016;60:858
    https://doi.org/10.1002/mnfr.201500814
  59. Carmen Rubio, Marta Puerto, Juan J. García-Rodríquez, Van B. Lu, Irma García-Martínez, Rosa Alén, Patricia Sanmartín-Salinas, M. Val Toledo-Lobo, Jorge Saiz, Javier Ruperez, Coral Barbas, Luis Menchén, Fiona M. Gribble, Frank Reimann, Luis G. Guijarro, Jose M. Carrascosa, Ángela M. Valverde. Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice. Molecular Metabolism 2020;35:100954
    https://doi.org/10.1016/j.molmet.2020.01.018
  60. Shamsul Mohd Zain, Rosmawati Mohamed, David N. Cooper, Rozaimi Razali, Sanjay Rampal, Sanjiv Mahadeva, Wah-Kheong Chan, Arif Anwar, Nurul Shielawati Mohamed Rosli, Anis Shafina Mahfudz, Phaik-Leng Cheah, Roma Choudhury Basu, Zahurin Mohamed, Yanqiao Zhang. Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease. PLoS ONE 2014;9:e95604
    https://doi.org/10.1371/journal.pone.0095604
  61. Maria Del Ben, Francesco Baratta, Licia Polimeni, Francesco Angelico. Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern Emerg Med 2012;7:291
    https://doi.org/10.1007/s11739-012-0819-4
  62. Geoffrey C. Farrell, Fahrettin Haczeyni, Shivakumar Chitturi. Obesity, Fatty Liver and Liver Cancer. 2012.
    https://doi.org/10.1007/978-981-10-8684-7_3
  63. Sebastian Zimny, Rebekka Pohl, Lisa Rein-Fischboeck, Elisabeth M. Haberl, Sabrina Krautbauer, Thomas S. Weiss, Christa Buechler. Chemokine (CC-motif) receptor-like 2 mRNA is expressed in hepatic stellate cells and is positively associated with characteristics of non-alcoholic steatohepatitis in mice and men. Experimental and Molecular Pathology 2017;103:1
    https://doi.org/10.1016/j.yexmp.2017.06.001
  64. Suvarthi Das, Ratanesh Kumar Seth, Ashutosh Kumar, Maria B. Kadiiska, Gregory Michelotti, Anna Mae Diehl, Saurabh Chatterjee. Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2013;305:G950
    https://doi.org/10.1152/ajpgi.00235.2013
  65. Emily Vogtmann, Xiao-Ou Shu, Hong-Lan Li, Wong-Ho Chow, Gong Yang, Bu-Tian Ji, Hui Cai, Chang Yu, Yu-Tang Gao, Wei Zheng, Yong-Bing Xiang. Cholelithiasis and the risk of liver cancer: results from cohort studies of 134 546 Chinese men and women. J Epidemiol Community Health 2014;68:565
    https://doi.org/10.1136/jech-2013-203503
  66. Angelique M. L. Scantlebery, Peter Ochodnicky, Lotte Kors, Elena Rampanelli, Loes M. Butter, Chaima El Boumashouli, Nike Claessen, Gwen J. Teske, Marius A. van den Bergh Weerman, Jaklien C. Leemans, Joris J. T. H. Roelofs, Sandrine Florquin. β-Cyclodextrin counteracts obesity in Western diet-fed mice but elicits a nephrotoxic effect. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-53890-z
  67. Myungsuk Kim, GyHye Yoo, Ahmad Randy, Hyoung Seok Kim, Chu Won Nho. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency. Mol. Nutr. Food Res. 2017;61:1600632
    https://doi.org/10.1002/mnfr.201600632
  68. Gina Coudriet, Meghan Delmastro-Greenwood, Dana Previte, Meghan Marré, Erin O’Connor, Elizabeth Novak, Garret Vincent, Kevin Mollen, Sojin Lee, H. Dong, Jon Piganelli. Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes. Antioxidants 2017;6:85
    https://doi.org/10.3390/antiox6040085
  69. Andrew D. Sauerbeck, J. Lukas Laws, Veera V.R. Bandaru, Phillip G. Popovich, Norman J. Haughey, Dana M. McTigue. Spinal Cord Injury Causes Chronic Liver Pathology in Rats. Journal of Neurotrauma 2015;32:159
    https://doi.org/10.1089/neu.2014.3497
  70. AiXuan Holterman, Juan Gurria, Smita Tanpure, Nerina DiSomma. Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Seminars in Pediatric Surgery 2014;23:49
    https://doi.org/10.1053/j.sempedsurg.2013.10.016
  71. Andrea M. Woltman, Andre Boonstra, Makoto Naito, Pieter J. M. Leenen. Macrophages: Biology and Role in the Pathology of Diseases. 2014.
    https://doi.org/10.1007/978-1-4939-1311-4_10
  72. Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2014.
    https://doi.org/10.1007/978-3-319-26956-6_164
  73. Akiko Eguchi, Davide Povero, Naim Alkhouri, Ariel E Feldstein. Novel therapeutic targets for nonalcoholic fatty liver disease. Expert Opinion on Therapeutic Targets 2013;17:773
    https://doi.org/10.1517/14728222.2013.789502
  74. Yuan Yuan, Hisao Naito, Xiaofang Jia, Kazuya Kitamori, Tamie Nakajima. Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways. Nutrients 2017;9:1018
    https://doi.org/10.3390/nu9091018
  75. Frederik Desmarais, Karl-F. Bergeron, Eric Rassart, Catherine Mounier. Apolipoprotein D overexpression alters hepatic prostaglandin and omega fatty acid metabolism during the development of a non-inflammatory hepatic steatosis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019;1864:522
    https://doi.org/10.1016/j.bbalip.2019.01.001
  76. Elaine Hui, Aimin Xu, Hong Bo Yang, Karen S L Lam. Obesity as the common soil of non-alcoholic fatty liver disease and diabetes: Role of adipokines. J Diabetes Invest 2013;4:413
    https://doi.org/10.1111/jdi.12093
  77. Yu-Sheng Lai, Tzu-Ching Yang, Po-Yuan Chang, Shwu-Fen Chang, Shu-Li Ho, Hui-Ling Chen, Shao-Chun Lu. Electronegative LDL is linked to high-fat, high-cholesterol diet–induced nonalcoholic steatohepatitis in hamsters. The Journal of Nutritional Biochemistry 2016;30:44
    https://doi.org/10.1016/j.jnutbio.2015.11.019
  78. Yong-Hyun Han, Hyeon-Ji Kim, Hyelin Na, Min-Woo Nam, Ju-Yeon Kim, Jun-Seok Kim, Seung-Hoi Koo, Mi-Ock Lee. RORα Induces KLF4-Mediated M2 Polarization in the Liver Macrophages that Protect against Nonalcoholic Steatohepatitis. Cell Reports 2017;20:124
    https://doi.org/10.1016/j.celrep.2017.06.017
  79. Maria Luíza R. P. Lima, Laura H. R. Leite, Carolina R. Gioda, Fabíola O. P. Leme, Claudia A. Couto, Cândido C. Coimbra, Virginia H. R. Leite, Teresa Cristina A. Ferrari. A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet. Journal of Diabetes Research 2016;2016:1
    https://doi.org/10.1155/2016/9127076
  80. Hong Lu, Xiaohong Lei, Qinghao Zhang. Moderate activation of IKK2-NF-kB in unstressed adult mouse liver induces cytoprotective genes and lipogenesis without apparent signs of inflammation or fibrosis. BMC Gastroenterol 2015;15
    https://doi.org/10.1186/s12876-015-0325-z
  81. Rocío Gallego-Durán, Pablo Cerro-Salido, Emilio Gomez-Gonzalez, María Jesús Pareja, Javier Ampuero, María Carmen Rico, Rafael Aznar, Eduardo Vilar-Gomez, Elisabetta Bugianesi, Javier Crespo, Francisco José González-Sánchez, Reyes Aparcero, Inmaculada Moreno, Susana Soto, María Teresa Arias-Loste, Javier Abad, Isidora Ranchal, Raúl Jesús Andrade, Jose Luis Calleja, Miguel Pastrana, Oreste Lo Iacono, Manuel Romero-Gómez. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Sci Rep 2016;6
    https://doi.org/10.1038/srep31421
  82. Zhang Wenfeng, Wu Yakun, Mu Di, Gong Jianping, Wu Chuanxin, Huang Chun. Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease. Annals of Hepatology 2014;13:489
    https://doi.org/10.1016/S1665-2681(19)31247-5
  83. Isaac T.W. Harley, Traci E. Stankiewicz, Daniel A. Giles, Samir Softic, Leah M. Flick, Monica Cappelletti, Rachel Sheridan, Stavra A. Xanthakos, Kris A. Steinbrecher, R. Balfour Sartor, Rohit Kohli, Christopher L. Karp, Senad Divanovic. IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology 2014;59:1830
    https://doi.org/10.1002/hep.26746
  84. Fahrettin Haczeyni, Matthew M Yeh, George N Ioannou, Isabelle A Leclercq, Robert Goldin, Yock Young Dan, Jun Yu, Narcissus C Teoh, Geoffrey C Farrell. Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. Journal of Gastroenterology and Hepatology 2018;33:1312
    https://doi.org/10.1111/jgh.14122
  85. Liyan Wu, Maoxiang Yan, Jianping Jiang, Beihui He, Wei Hong, Zhiyun Chen. Pure total flavonoids from citrus improve non-alcoholic fatty liver disease by regulating TLR/CCL signaling pathway: A preliminary high-throughput ‘omics’ study. Biomedicine & Pharmacotherapy 2017;93:316
    https://doi.org/10.1016/j.biopha.2017.04.128
  86. Woo-Jin Yi, Tae Sung Kim. Melatonin protects mice against stress-induced inflammation through enhancement of M2 macrophage polarization. International Immunopharmacology 2017;48:146
    https://doi.org/10.1016/j.intimp.2017.05.006
  87. Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Vimal Pandey, Jomon Joseph, Rajashekar Mohan, Praveen Kumar Shetty, Manoj Kumar Bhat. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4. Sci Rep 2016;6
    https://doi.org/10.1038/srep27558
  88. G. Song, H. Vollbrecht. Translating MicroRNAs to the Clinic. 2016.
    https://doi.org/10.1016/B978-0-12-800553-8.00005-6
  89. Vishal Patel, Amit Joharapurkar, Samadhan Kshirsagar, Maulik Patel, Brijesh Sutariya, Hiren Patel, Dheerendra Pandey, Dipam Patel, Ramchandra Ranvir, Shekhar Kadam, Rajesh Bahekar, Mukul Jain. Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease. Can. J. Physiol. Pharmacol. 2018;96:587
    https://doi.org/10.1139/cjpp-2017-0683
  90. Doyoung Kwon, Sung-Mi Kim, Maria Almira Correia. Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications. Acta Pharmaceutica Sinica B 2020;10:42
    https://doi.org/10.1016/j.apsb.2019.11.002
  91. François Briand, Christophe Heymes, Lucile Bonada, Thibault Angles, Julie Charpentier, Maxime Branchereau, Emmanuel Brousseau, Marjolaine Quinsat, Nicolas Fazilleau, Rémy Burcelin, Thierry Sulpice. A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death. Clin Transl Sci 2020;13:529
    https://doi.org/10.1111/cts.12735
  92. Joseph Salamoun, Christopher J Garcia, Stefan Hargett, Jacob Murray, Sing-Young Chen, Martina Baretta, Stephanie Alexopoulos, Divya Shah, Ellen Olzomer, Simon Tucker, Kyle Hoehn, Webster L. Santos. 6-Amino-[1,2,5]oxadiazolo[3,4-b]pyrazin-5-ol Derivatives as Efficacious Mitochondrial Uncouplers in STAM Mouse Model of Non-alcoholic Steatohepatitis. J. Med. Chem. 2020
    https://doi.org/10.1021/acs.jmedchem.0c00542
  93. Yong-Hyun Han, Hyeon-Ji Kim, Eun-Jin Kim, Kyu-Seo Kim, Suckchang Hong, Hyeung-Geun Park, Mi-Ock Lee. RORα Decreases Oxidative Stress Through the Induction of SOD2 and GPx1 Expression and Thereby Protects Against Nonalcoholic Steatohepatitis in Mice. Antioxidants & Redox Signaling 2014;21:2083
    https://doi.org/10.1089/ars.2013.5655
  94. Jieyi Li, Dipanjan Chanda, Patrick J. van Gorp, Mike L. J. Jeurissen, Tom Houben, Sofie M. A. Walenbergh, Jacques Debets, Yvonne Oligschlaeger, Marion J. J. Gijbels, Dietbert Neumann, Ronit Shiri-Sverdlov, Hervé Guillou. Macrophage Stimulating Protein Enhances Hepatic Inflammation in a NASH Model. PLoS ONE 2016;11:e0163843
    https://doi.org/10.1371/journal.pone.0163843
  95. Ian James Martins, Wei Ling Florence Lim, Andrea C. Wilson, Simon M. Laws, Ralph Nigel Martins. The acceleration of aging and Alzheimer’s disease through the biological mechanisms behind obesity and type II diabetes. Health 2013;05:913
    https://doi.org/10.4236/health.2013.55121
  96. Xinwei Jiang, Xusheng Li, Cuijuan Zhu, Jianxia Sun, Lingmin Tian, Wei Chen, Weibin Bai. The target cells of anthocyanins in metabolic syndrome. Critical Reviews in Food Science and Nutrition 2019;59:921
    https://doi.org/10.1080/10408398.2018.1491022
  97. Svitlana Shpyleva, Marta Pogribna, Christy Cozart, Matthew S. Bryant, Levan Muskhelishvili, Volodymyr P. Tryndyak, Sharon A. Ross, Frederick A. Beland, Igor P. Pogribny. Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. The Journal of Nutritional Biochemistry 2014;25:1235
    https://doi.org/10.1016/j.jnutbio.2014.06.012
  98. Sandra Winkler, Erawan Borkham-Kamphorst, Peggy Stock, Sandra Brückner, Matthias Dollinger, Ralf Weiskirchen, Bruno Christ. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Experimental Cell Research 2014;326:230
    https://doi.org/10.1016/j.yexcr.2014.04.017
  99. Yong Zhou, Yin-Lu Ding, Jian-Liang Zhang, Peng Zhang, Jin-Qing Wang, Zhao-Hua Li. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. Biomedicine & Pharmacotherapy 2018;97:1397
    https://doi.org/10.1016/j.biopha.2017.10.035
  100. Shiori Takashima, Kenichi Ikejima, Kumiko Arai, Junko Yokokawa, Kazuyoshi Kon, Shunhei Yamashina, Sumio Watanabe. Glycine prevents metabolic steatohepatitis in diabetic KK-Ay mice through modulation of hepatic innate immunity. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016;311:G1105
    https://doi.org/10.1152/ajpgi.00465.2015
  101. Manuel Romero-Gómez, Shira Zelber-Sagi, Michael Trenell. Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology 2017;67:829
    https://doi.org/10.1016/j.jhep.2017.05.016
  102. Ali Akbar Hajiaghamohammadi, Amir Ziaee, Sonia Oveisi, Homa Masroor. Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study. Hepat Mon 2012;12
    https://doi.org/10.5812/hepatmon.6099
  103. Joy X. Jiang, Natalie J. Török. MLK3 as a regulator of disease progression in Non-alcoholic steatohepatitis. Liver Int 2014;34:1131
    https://doi.org/10.1111/liv.12556
  104. Emma T. Saltzman, Talia Palacios, Michael Thomsen, Luis Vitetta. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease. Front. Microbiol. 2018;9
    https://doi.org/10.3389/fmicb.2018.00061
  105. Sara Manteiga, Kyungoh Choi, Arul Jayaraman, Kyongbum Lee. Systems biology of adipose tissue metabolism: regulation of growth, signaling and inflammation. WIREs Syst Biol Med 2013;5:425
    https://doi.org/10.1002/wsbm.1213
  106. David Porras, Esther Nistal, Susana Martínez-Flórez, Sandra Pisonero-Vaquero, José Luis Olcoz, Ramiro Jover, Javier González-Gallego, María Victoria García-Mediavilla, Sonia Sánchez-Campos. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Free Radical Biology and Medicine 2017;102:188
    https://doi.org/10.1016/j.freeradbiomed.2016.11.037
  107. Yong-Hyun Han, Kyong-Oh Shin, Ju-Yeon Kim, Daulat B. Khadka, Hyeon-Ji Kim, Yong-Moon Lee, Won-Jea Cho, Ji-Young Cha, Bong-Jin Lee, Mi-Ock Lee. A maresin 1/RORα/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis. 2019;129:1684
    https://doi.org/10.1172/JCI124219
  108. Claudia Isabel García-Berumen, Omar Ortiz-Avila, Manuel Alejandro Vargas-Vargas, Bricia A. del Rosario-Tamayo, Clotilde Guajardo-López, Alfredo Saavedra-Molina, Alain Raimundo Rodríguez-Orozco, Christian Cortés-Rojo. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria. Lipids Health Dis 2019;18
    https://doi.org/10.1186/s12944-019-1024-5
  109. Jinhang Zhang, Yanping Li, Qinhui Liu, Rui Li, Shiyun Pu, Lina Yang, Yanhuan Feng, Liang Ma. SKLB023 as an iNOS inhibitor alleviated liver fibrosis by inhibiting the TGF-beta/Smad signaling pathway. RSC Adv. 2018;8:30919
    https://doi.org/10.1039/C8RA04955F
  110. Derrick M. Van Rooyen, Lay T. Gan, Matthew M. Yeh, W. Geoffrey Haigh, Claire Z. Larter, George Ioannou, Narci C. Teoh, Geoffrey C. Farrell. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome. Journal of Hepatology 2013;59:144
    https://doi.org/10.1016/j.jhep.2013.02.024
  111. Anna Nakamura, Qi Zhu, Yoko Yokoyama, Naho Kitamura, Sena Uchida, Kayo Kumadaki, Kazuo Tsubota, Mitsuhiro Watanabe. Agaricus brasiliensis KA21 May Prevent Diet-Induced Nash Through Its Antioxidant, Anti-Inflammatory, and Anti-Fibrotic Activities in the Liver. Foods 2019;8:546
    https://doi.org/10.3390/foods8110546
  112. An Zou, Nancy Magee, Fengyan Deng, Sarah Lehn, Cuncong Zhong, Yuxia Zhang. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. J. Biol. Chem. 2018;293:8656
    https://doi.org/10.1074/jbc.RA117.001653
  113. Shan Zhong, Lei Zhao, Yan Wang, Chang Zhang, Jun Liu, Pei Wang, Wei Zhou, Ping Yang, Zac Varghese, John F. Moorhead, Yaxi Chen, Xiong Z. Ruan. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway. Antioxidants & Redox Signaling 2017;27:201
    https://doi.org/10.1089/ars.2016.6808
  114. Marie Liebig, Alireza Hassanzada, Malte Kämmerling, Berit Genz, Brigitte Vollmar, Kerstin Abshagen. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors. Exp Biol Med (Maywood) 2018;243:1
    https://doi.org/10.1177/1535370217738730
  115. Claudia Della Corte, Daniela Liccardo, Antonella Mosca, Andrea Vania, Valerio Nobili. Non-alcoholic fatty liver disease. Paediatrics and Child Health 2013;23:529
    https://doi.org/10.1016/j.paed.2013.08.003
  116. Martine C. Morrison, Wen Liang, Petra Mulder, Lars Verschuren, Elsbet Pieterman, Karin Toet, Peter Heeringa, Peter Y. Wielinga, Teake Kooistra, Robert Kleemann. Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE∗3Leiden mice. Journal of Hepatology 2015;62:1180
    https://doi.org/10.1016/j.jhep.2014.12.011
  117. Ju Youn Kim, Ricard Garcia-Carbonell, Shinichiro Yamachika, Peng Zhao, Debanjan Dhar, Rohit Loomba, Randal J. Kaufman, Alan R. Saltiel, Michael Karin. ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P. Cell 2018;175:133
    https://doi.org/10.1016/j.cell.2018.08.020
  118. Xiang Zhang, Jiayun Shen, Kwan Man, Eagle S.H. Chu, Tung On Yau, Joanne C.Y. Sung, Minnie Y.Y. Go, Jun Deng, Liwei Lu, Vincent W.S. Wong, Joseph J.Y. Sung, Geoffrey Farrell, Jun Yu. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. Journal of Hepatology 2014;61:1365
    https://doi.org/10.1016/j.jhep.2014.07.006
  119. Barbara Schmidinger, Anna M. Weijler, Wolfgang J. Schneider, Marcela Hermann. Hepatosteatosis and estrogen increase apolipoprotein O production in the chicken. Biochimie 2016;127:37
    https://doi.org/10.1016/j.biochi.2016.04.017
  120. Mitchell R. McGill, Benjamin L. Woolbright, James L. Weemhoff, Hartmut Jaeschke. Biomarkers in Liver Disease. 2016.
    https://doi.org/10.1007/978-94-007-7742-2_5-1
  121. Isabella Reccia, Jayant Kumar, Cherif Akladios, Francesco Virdis, Madhava Pai, Nagy Habib, Duncan Spalding. Non-alcoholic fatty liver disease: A sign of systemic disease. Metabolism 2017;72:94
    https://doi.org/10.1016/j.metabol.2017.04.011
  122. Junli Zhang, Haiming Zhang, Xiaoling Deng, Ning Zhang, Beibei Liu, Shengliang Xin, Guixin Li, Keshu Xu. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. Life Sciences 2018;192:46
    https://doi.org/10.1016/j.lfs.2017.11.027
  123. Williams Puszyk, Keith Robertson, Chen Liu. Precision Molecular Pathology of Liver Cancer. 2018.
    https://doi.org/10.1007/978-3-319-68082-8_5
  124. Nicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, Sonja M. Kessler, Julia Unterluggauer, Stefanie Krassnig, Kensuke Kojima, Xintong Chen, Yujin Hoshida, Nabeel M. Bardeesy, Heimo Müller, Vendula Svendova, Michael G. Schimek, Clemens Diwoky, Alexandra Lipfert, Vineet Mahajan, Cornelia Stumptner, Andrea Thüringer, Leopold F. Fröhlich, Tatjana Stojakovic, K.P.R. Nilsson, Thomas Kolbe, Thomas Rülicke, Thomas M. Magin, Pavel Strnad, Alexandra K. Kiemer, Richard Moriggl, Johannes Haybaeck. High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype. Translational Oncology 2019;12:256
    https://doi.org/10.1016/j.tranon.2018.10.010
  125. Akifumi Kushiyama, Yusuke Nakatsu, Yasuka Matsunaga, Takeshi Yamamotoya, Keiichi Mori, Koji Ueda, Yuki Inoue, Hideyuki Sakoda, Midori Fujishiro, Hiraku Ono, Tomoichiro Asano. Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators of Inflammation 2016;2016:1
    https://doi.org/10.1155/2016/8603164
  126. Ali Mahzari, Songpei Li, Xiu Zhou, Dongli Li, Sherouk Fouda, Majid Alhomrani, Wala Alzahrani, Stephen R. Robinson, Ji-Ming Ye. Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin. Front. Pharmacol. 2019;10
    https://doi.org/10.3389/fphar.2019.00405
  127. Xiang-Wen Gong, Yong-Jian Xu, Qin-He Yang, Yin-Ji Liang, Yu-Pei Zhang, Guan-Long Wang, Yuan-Yuan Li. Effects of Soothing Liver and Invigorating Spleen Recipes on the IKKβ-NF-κB Signaling Pathway in Kupffer Cells of Nonalcoholic Steatohepatitis Rats. Evidence-Based Complementary and Alternative Medicine 2015;2015:1
    https://doi.org/10.1155/2015/687690
  128. Jianmei Li, Xiwei He, Yang Yang, Mei Li, Chenke Xu, Rong Yu. Risk assessment of silica nanoparticles on liver injury in metabolic syndrome mice induced by fructose. Science of The Total Environment 2018;628-629:366
    https://doi.org/10.1016/j.scitotenv.2018.02.047
  129. Jessica L Mueller, Eoin R Feeney, Hui Zheng, Joseph Misdraji, Annie J Kruger, Nadia Alatrakchi, Lindsay Y King, Louis Gelrud, Kathleen E Corey, Raymond T Chung. Circulating Soluble CD163 is Associated with Steatohepatitis and Advanced Fibrosis in Nonalcoholic Fatty Liver Disease. Clinical and Translational Gastroenterology 2015;6:e114
    https://doi.org/10.1038/ctg.2015.36
  130. Yoshihiro Komohara, Yukio Fujiwara, Koji Ohnishi, Daisuke Shiraishi, Motohiro Takeya. Contribution of Macrophage Polarization to Metabolic Diseases. J Atheroscler Thromb 2016;23:10
    https://doi.org/10.5551/jat.32359
  131. Yumi Akahori, Kyousuke Yamashita, Kazuya Ishida, Fumiyo Saito, Makoto Nakai. Transcriptomics-driven Evaluation on Liver Toxicity Using Adverse Outcome Pathways (AOP). YAKUGAKU ZASSHI 2020;140:491
    https://doi.org/10.1248/yakushi.19-00190-3
  132. Susann Blüher, Matthias Raschpichler, Wolfgang Hirsch, Holger Till. A case report and review of the literature of laparoscopic sleeve gastrectomy in morbidly obese adolescents: Beyond metabolic surgery and visceral fat reduction. Metabolism 2013;62:761
    https://doi.org/10.1016/j.metabol.2012.11.001
  133. Byung Han Park, Jung Min Yoon, Ja Hye Kim, Jin-Hwa Moon, Young Ho Lee, Se Min Jang, Yong Joo Kim. Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis. Yonsei Med J 2017;58:756
    https://doi.org/10.3349/ymj.2017.58.4.756
  134. Diren Beyoğlu, Jeffrey R. Idle. The metabolomic window into hepatobiliary disease. Journal of Hepatology 2013;59:842
    https://doi.org/10.1016/j.jhep.2013.05.030
  135. Guangda Xin, Shaoyou Qin, Song Wang, Xu Wang, Yonggui Zhang, Jiangbin Wang. Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway. Exp Biol Med (Maywood) 2015;240:1279
    https://doi.org/10.1177/1535370215570189
  136. Valentina Medici. The Evolving Scenario of Copper and Fatty Liver. Metabolic Syndrome and Related Disorders 2013;11:4
    https://doi.org/10.1089/met.2013.1501
  137. Syam S. Andra, Pantelis Charisiadis, Konstantinos C. Makris. Obesity-mediated association between exposure to brominated trihalomethanes and type II diabetes mellitus: An exploratory analysis. Science of The Total Environment 2014;485-486:340
    https://doi.org/10.1016/j.scitotenv.2014.03.075
  138. Sophie Cazanave, Alexei Podtelezhnikov, Kristian Jensen, Mulugeta Seneshaw, Divya P. Kumar, Hae-Ki Min, Prasanna K. Santhekadur, Bubu Banini, Adolfo Gabriele Mauro, Abdul M. Oseini, Robert Vincent, Keith Q. Tanis, Andrea L. Webber, Liangsu Wang, Pierre Bedossa, Faridoddin Mirshahi, Arun J. Sanyal. The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease. Sci Rep 2017;7
    https://doi.org/10.1038/s41598-017-17370-6
  139. Laura J Carbone, Peter W Angus, Neville D Yeomans. Incretin-based therapies for the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology 2016;31:23
    https://doi.org/10.1111/jgh.13026
  140. Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016.
    https://doi.org/10.1007/978-3-319-26587-2_164-1
  141. RYUICHIRO SAKATA, TORU NAKAMURA, TAKUJI TORIMURA, TAKATO UENO, MICHIO SATA. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study. 2013;32:989
    https://doi.org/10.3892/ijmm.2013.1503
  142. Chun-Lin Qian, Cui-Ling Ding, Hai-Lin Tang, Zhong-Tian Qi, Wen Wang. Retinoic acid induced 16 deficiency exacerbates high-fat diet-induced steatohepatitis in mice. Cell Biochem Funct 2020
    https://doi.org/10.1002/cbf.3542
  143. Peter Hauff, Ulrich Gottwald, Matthias Ocker. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. Expert Opinion on Investigational Drugs 2015;24:309
    https://doi.org/10.1517/13543784.2015.997874
  144. Umakant Ashok Bahirat, Rekha Raghuveer Shenoy, Rashmi Talwar, Rajan Naresh Goel, Kumar V.S. Nemmani. Co-administration of APD668, a G protein-coupled receptor 119 agonist and linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in mice fed on a high trans-fat diet. Biochemical and Biophysical Research Communications 2018;495:1608
    https://doi.org/10.1016/j.bbrc.2017.12.004
  145. Huimin Hou, Wanli Yang, Suqing Bao, Yanli Cao. Epigallocatechin Gallate Suppresses Inflammatory Responses by Inhibiting Toll-like Receptor 4 Signaling and Alleviates Insulin Resistance in the Livers of High-fat-diet Rats. J. Oleo Sci. 2020;69:479
    https://doi.org/10.5650/jos.ess19303
  146. Suvarthi Das, Firas Alhasson, Diptadip Dattaroy, Sahar Pourhoseini, Ratanesh Kumar Seth, Mitzi Nagarkatti, Prakash S. Nagarkatti, Gregory A. Michelotti, Anna Mae Diehl, Balaraman Kalyanaraman, Saurabh Chatterjee. NADPH Oxidase–Derived Peroxynitrite Drives Inflammation in Mice and Human Nonalcoholic Steatohepatitis via TLR4-Lipid Raft Recruitment. The American Journal of Pathology 2015;185:1944
    https://doi.org/10.1016/j.ajpath.2015.03.024
  147. Simon Hazeldine, Debbie Trinder, John K. Olynyk. Non-Hfe Iron Overload: Is Phlebotomy the Answer?. Curr Hepatitis Rep 2013;12:20
    https://doi.org/10.1007/s11901-012-0153-3
  148. Xuemei Jia, Stephen Iwanowycz, Junfeng Wang, Fatma Saaoud, Fang Yu, Yuzhen Wang, Jun Hu, Saurabh Chatterjee, Qian Wang, Daping Fan. Emodin attenuates systemic and liver inflammation in hyperlipidemic mice administrated with lipopolysaccharides. Exp Biol Med (Maywood) 2014;239:1025
    https://doi.org/10.1177/1535370214530247
  149. Rocío Gallego-Durán. Epigenetic mechanisms in non-alcoholic fatty liver disease: An emerging field. WJH 2015;7:2497
    https://doi.org/10.4254/wjh.v7.i24.2497
  150. Karim Gariani, Dongryeol Ryu, Keir J. Menzies, Hyon-Seung Yi, Sokrates Stein, Hongbo Zhang, Alessia Perino, Vera Lemos, Elena Katsyuba, Pooja Jha, Sandrine Vijgen, Laura Rubbia-Brandt, Yong Kyung Kim, Jung Tae Kim, Koon Soon Kim, Minho Shong, Kristina Schoonjans, Johan Auwerx. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. Journal of Hepatology 2017;66:132
    https://doi.org/10.1016/j.jhep.2016.08.024
  151. Umakant Ashok Bahirat, Rashmi Talwar, Rekha Raghuveer Shenoy, Kumar V. S. Nemmani, Rajan Naresh Goel. Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes. Med Mol Morphol 2019;52:36
    https://doi.org/10.1007/s00795-018-0200-4
  152. Ferah Armutcu, Sumeyya Akyol, Fatma Ucar, Serpil Erdogan, Omer Akyol. . 2019.
    https://doi.org/10.1016/B978-0-12-407680-8.00004-X
  153. Ali Sazci, Mavi Deniz Ozel, Emel Ergul, Cem Aygun. Association of Nicotinamide-N-Methyltransferase Gene rs694539 Variant with Patients with Nonalcoholic Steatohepatitis. Genetic Testing and Molecular Biomarkers 2013;17:849
    https://doi.org/10.1089/gtmb.2013.0309
  154. Y. TORINIWA, M. MURAMATSU, Y. ISHII, E. RIYA, K. MIYAJIMA, S. OHSHIDA, K. KITATANI, S. TAKEKOSHI, T. MATSUI, S. KUME, T. YAMADA, T. OHTA. Pathophysiological Characteristics of Non-Alcoholic Steatohepatitis-Like Changes in Cholesterol-Loaded Type 2 Diabetic Rats. Physiol Res 2018:601
    https://doi.org/10.33549/physiolres.933784
  155. Dongmin Li, Xuan Wang, Xi Lan, Yue Li, Li Liu, Jing Yi, Jing Li, Qingzhu Sun, Yili Wang, Hongmin Li, Nannan Zhong, Rikard Holmdahl, Shemin Lu. Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats. Molecular and Cellular Endocrinology 2015;402:1
    https://doi.org/10.1016/j.mce.2014.12.007
  156. Marine Coué, Angela Tesse, Juliette Falewée, Audrey Aguesse, Mikaël Croyal, Lionel Fizanne, Julien Chaigneau, Jérôme Boursier, Khadija Ouguerram. Spirulina Liquid Extract Protects against Fibrosis Related to Non-Alcoholic Steatohepatitis and Increases Ursodeoxycholic Acid. Nutrients 2019;11:194
    https://doi.org/10.3390/nu11010194
  157. Xiang Zhang, Juqiang Han, Kwan Man, Xiaoxing Li, Jinghua Du, Eagle S.H. Chu, Minnie Y.Y. Go, Joseph J.Y. Sung, Jun Yu. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy. Journal of Hepatology 2016;64:160
    https://doi.org/10.1016/j.jhep.2015.09.005
  158. Lorenza Putignani, Federica Del Chierico, Andrea Petrucca, Pamela Vernocchi, Bruno Dallapiccola. The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood. Pediatr Res 2014;76:2
    https://doi.org/10.1038/pr.2014.49
  159. Adriana Carino, Sabrina Cipriani, Silvia Marchianò, Michele Biagioli, Chiara Santorelli, Annibale Donini, Angela Zampella, Maria Chiara Monti, Stefano Fiorucci. BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis. Sci Rep 2017;7
    https://doi.org/10.1038/srep42801
  160. Feliciano Chanana Paquissi. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Front. Immunol. 2016;7
    https://doi.org/10.3389/fimmu.2016.00490
  161. Martine C. Morrison, Petra Mulder, P. Mark Stavro, Manuel Suárez, Anna Arola-Arnal, Wim van Duyvenvoorde, Teake Kooistra, Peter Y. Wielinga, Robert Kleemann, Xuewei Zhu. Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil. PLoS ONE 2015;10:e0139196
    https://doi.org/10.1371/journal.pone.0139196
  162. Sarthak Sahoo, Divyoj Singh, Priyanka Chakraborty, Mohit Kumar Jolly. Emergent Properties of the HNF4α-PPARγ Network May Drive Consequent Phenotypic Plasticity in NAFLD. JCM 2020;9:870
    https://doi.org/10.3390/jcm9030870
  163. Sookyoung Jeon, Youn-Jin Park, Young Hye Kwon. Genistein alleviates the development of nonalcoholic steatohepatitis inApoE―/―mice fed a high-fat diet. Mol. Nutr. Food Res. 2014;58:830
    https://doi.org/10.1002/mnfr.201300112
  164. D. T. Reid, B. Eksteen. Murine models provide insight to the development of non-alcoholic fatty liver disease. Nutr. Res. Rev. 2015;28:133
    https://doi.org/10.1017/S0954422415000128
  165. Christophe Regnault, John Willison, Sylvie Veyrenc, Antinéa Airieau, Patrick Méresse, Marlène Fortier, Michel Fournier, Pauline Brousseau, Muriel Raveton, Stéphane Reynaud. Metabolic and immune impairments induced by the endocrine disruptors benzo[ a ]pyrene and triclosan in Xenopus tropicalis. Chemosphere 2016;155:519
    https://doi.org/10.1016/j.chemosphere.2016.04.047
  166. Lu-Min Shih, Hsiang-Yu Tang, Ke-Shiuan Lynn, Cheng-Yu Huang, Hung-Yao Ho, Mei-Ling Cheng. Stable Isotope-Labeled Lipidomics to Unravel the Heterogeneous Development Lipotoxicity. Molecules 2018;23:2862
    https://doi.org/10.3390/molecules23112862
  167. Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, David Montefusco, L. Ashley Cowart, Pierre Bedossa, Arun J. Sanyal, Sarah Spiegel. FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. J. Lipid Res. 2019;60:1311
    https://doi.org/10.1194/jlr.M093799
  168. Amon Asgharpour, Sophie C. Cazanave, Tommy Pacana, Mulugeta Seneshaw, Robert Vincent, Bubu A. Banini, Divya Prasanna Kumar, Kalyani Daita, Hae-Ki Min, Faridoddin Mirshahi, Pierre Bedossa, Xiaochen Sun, Yujin Hoshida, Srinivas V. Koduru, Daniel Contaifer, Urszula Osinska Warncke, Dayanjan S. Wijesinghe, Arun J. Sanyal. A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer. Journal of Hepatology 2016;65:579
    https://doi.org/10.1016/j.jhep.2016.05.005
  169. Adam C. Labonte, Annie-Carole Tosello-Trampont, Young S. Hahn. The Role of Macrophage Polarization in Infectious and Inflammatory Diseases. 2014;37:275
    https://doi.org/10.14348/molcells.2014.2374
  170. Eugene Chang, Dae-Hee Kim, Hyekyung Yang, Da Hyun Lee, Soo Han Bae, Cheol-Young Park, Pavel Strnad. CB1 receptor blockade ameliorates hepatic fat infiltration and inflammation and increases Nrf2-AMPK pathway in a rat model of severely uncontrolled diabetes. PLoS ONE 2018;13:e0206152
    https://doi.org/10.1371/journal.pone.0206152
  171. Torsten Schröder, Klaus J. Schmidt, Vera Olsen, Steffen Möller, Tilo Mackenroth, Christian Sina, Hendrik Lehnert, Klaus Fellermann, Jürgen Büning. Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment. European Journal of Gastroenterology & Hepatology 2015;27:698
    https://doi.org/10.1097/MEG.0000000000000350
  172. Zhilu Xu, Xiang Zhang, Jennie Lau, Jun Yu. C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication. Expert Rev. Mol. Med. 2016;18
    https://doi.org/10.1017/erm.2016.16
  173. Kazuki Takakura, Tsunekazu Oikawa, Masanori Nakano, Chisato Saeki, Yuichi Torisu, Mikio Kajihara, Masayuki Saruta. Recent Insights Into the Multiple Pathways Driving Non-alcoholic Steatohepatitis-Derived Hepatocellular Carcinoma. Front. Oncol. 2019;9
    https://doi.org/10.3389/fonc.2019.00762
  174. Zhihong Ma, Li Chu, Hongying Liu, Jieru Li, Yuanyuan Zhang, Wentai Liu, Jun Dai, Jianfeng Yi, Yue Gao. Paeoniflorin alleviates non-alcoholic steatohepatitis in rats: Involvement with the ROCK/NF-κB pathway. International Immunopharmacology 2016;38:377
    https://doi.org/10.1016/j.intimp.2016.06.023
  175. Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis, Dimitri P Mikhailidis. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. WJG 2015;21:6820
    https://doi.org/10.3748/wjg.v21.i22.6820
  176. Mingzuo Jiang, Nan Wu, Xi Chen, Weijie Wang, Yi Chu, Hao Liu, Wenjiao Li, Di Chen, Xiaowei Li, Bing Xu. Pathogenesis of and major animal models used for nonalcoholic fatty liver disease. J Int Med Res 2019;47:1453
    https://doi.org/10.1177/0300060519833527
  177. Jiawei Li, Paul Cordero, Jude A. Oben. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease. 2019.
    https://doi.org/10.1002/9781118924938.ch26
  178. Chun-Yan Song, Xin Zeng, Yang Wang, Jian Shi, Hui Qian, Yi Zhang, Jia-Qing Fang, Xia Sheng, Jian-Ming Zheng, Yue-Xiang Chen. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis. J Gastroenterol Hepatol 2015;30:405
    https://doi.org/10.1111/jgh.12691
  179. Hayato Nakagawa, Atsushi Umemura, Koji Taniguchi, Joan Font-Burgada, Debanjan Dhar, Hisanobu Ogata, Zhenyu Zhong, Mark A. Valasek, Ekihiro Seki, Juan Hidalgo, Kazuhiko Koike, Randal J. Kaufman, Michael Karin. ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development. Cancer Cell 2014;26:331
    https://doi.org/10.1016/j.ccr.2014.07.001
  180. Joo Lee, Simonetta Friso, Sang-Woon Choi. Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition. Nutrients 2014;6:3303
    https://doi.org/10.3390/nu6083303
  181. Amanda X. Chen, Arnav Chhabra, Heather E. Fleming, Sangeeta N. Bhatia. Principles of Tissue Engineering. 2014.
    https://doi.org/10.1016/B978-0-12-818422-6.00041-1
  182. Christoph Dorn, Julia C Engelmann, Michael Saugspier, Andreas Koch, Arndt Hartmann, Martina Müller, Rainer Spang, Anja Bosserhoff, Claus Hellerbrand. Increased expression of c-Jun in nonalcoholic fatty liver disease. Lab Invest 2014;94:394
    https://doi.org/10.1038/labinvest.2014.3
  183. Sofie M.A. Walenbergh, Ger H. Koek, Veerle Bieghs, Ronit Shiri-Sverdlov. Non-alcoholic steatohepatitis: The role of oxidized low-density lipoproteins. Journal of Hepatology 2013;58:801
    https://doi.org/10.1016/j.jhep.2012.11.014
  184. Nadia Pallotta, Tiziana Filardi, Anna Carnovale, Luciano Nieddu, Paola Mariani, Giuseppina Vincoli, Andrea Lenzi, Susanna Morano. Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study. Endocrine 2017;57:352
    https://doi.org/10.1007/s12020-016-1008-4
  185. Jashdeep Bhattacharjee, Michelle Kirby, Samir Softic, Lili Miles, Rosa-Maria Salazar-Gonzalez, Pranav Shivakumar, Rohit Kohli. Hepatic natural killer T-cell and CD8+ T-cell signatures in mice with nonalcoholic steatohepatitis. Hepatology Communications 2017;1:299
    https://doi.org/10.1002/hep4.1041
  186. Matthew T. Goodus, Andrew D. Sauerbeck, Phillip G. Popovich, Richard S. Bruno, Dana M. McTigue. Dietary Green Tea Extract Prior to Spinal Cord Injury Prevents Hepatic Iron Overload but Does Not Improve Chronic Hepatic and Spinal Cord Pathology in Rats. Journal of Neurotrauma 2018;35:2872
    https://doi.org/10.1089/neu.2018.5771
  187. Li Li, Shawn Somerset. The clinical significance of the gut microbiota in cystic fibrosis and the potential for dietary therapies. Clinical Nutrition 2014;33:571
    https://doi.org/10.1016/j.clnu.2014.04.004
  188. Xiang-wen Gong, Yong-jian Xu, Qin-he Yang, Yin-ji Liang, Yu-pei Zhang, Guan-long Wang, Yuan-yuan Li. Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats. Chin. J. Integr. Med. 2019;25:216
    https://doi.org/10.1007/s11655-018-2829-6
  189. José Del Campo, Rocío Gallego-Durán, Paloma Gallego, Lourdes Grande. Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD). IJMS 2018;19:911
    https://doi.org/10.3390/ijms19030911
  190. R. Xu, A. Tao, S. Zhang, M. Zhang. Neutralization of interleukin-17 attenuates high fat diet-induced non-alcoholic fatty liver disease in mice. Acta Biochimica et Biophysica Sinica 2013;45:726
    https://doi.org/10.1093/abbs/gmt065
  191. Zhiwen Fan, Luyang Li, Min Li, Xinjian Zhang, Chenzhi Hao, Liming Yu, Sheng Zeng, Huihui Xu, Mingming Fang, Aiguo Shen, Thomas Jenuwein, Yong Xu. The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. Hepatology 2017;65:1904
    https://doi.org/10.1002/hep.29127
  192. David Højland Ipsen, Pernille Tveden-Nyborg, Jens Lykkesfeldt. Normal weight dyslipidemia: Is it all about the liver?. Obesity 2016;24:556
    https://doi.org/10.1002/oby.21443
  193. Lulu Wang, Susu Wu, Minxuan Cai, Ji Ma, Shengcun Li, Maoru Li, Yan Xu, Lixin Wei, Jing Shang. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. IJMS 2017;18:1681
    https://doi.org/10.3390/ijms18081681
  194. Ali Akbar Hajiaghamohammadi, Amir Ziaee, Sonia Oveisi, Homa Masroor. Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study. Hepat Mon 2012;12
    https://doi.org/10.5812/hapatmon.6099
  195. Denise Lima Feksa, Ritiéle Pinto Coelho, Angélica Aparecida da Costa Güllich, Emanuelle S. Dal Ponte, Jacqueline da Costa Escobar Piccoli, Vanusa Manfredini. Extract of Citrus maxima (pummelo) leaves improve hepatoprotective activity in Wistar rats submitted to the induction of non-alcoholic hepatic steatosis. Biomedicine & Pharmacotherapy 2018;98:338
    https://doi.org/10.1016/j.biopha.2017.12.070
  196. Federica Del Chierico, Daniela Gnani, Pamela Vernocchi, Andrea Petrucca, Anna Alisi, Bruno Dallapiccola, Valerio Nobili, Putignani Lorenza. Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications. IJMS 2014;15:684
    https://doi.org/10.3390/ijms15010684
  197. Jérémie Gautheron, Gregory J. Gores, Cecília M.P. Rodrigues. Lytic cell death in metabolic liver disease. Journal of Hepatology 2020
    https://doi.org/10.1016/j.jhep.2020.04.001
  198. Francisco Barrera, Jacob George. Non-alcoholic fatty liver disease: more than just ectopic fat accumulation. Drug Discovery Today: Disease Mechanisms 2013;10:e47
    https://doi.org/10.1016/j.ddmec.2013.06.002
  199. Sung-Mi Kim, James P. Grenert, Cam Patterson, Maria Almira Correia. CHIP−/−-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications. Sci Rep 2016;6
    https://doi.org/10.1038/srep29423
  200. Mariana Verdelho Machado. Non-alcoholic fatty liver disease: What the clinician needs to know. WJG 2014;20:12956
    https://doi.org/10.3748/wjg.v20.i36.12956
  201. Go Woon Kim, Hee Kyung Jo, Sung Hyun Chung. Ginseng seed oil ameliorates hepatic lipid accumulation in vitro and in vivo. Journal of Ginseng Research 2018;42:419
    https://doi.org/10.1016/j.jgr.2017.04.010
  202. Wenjiao Jiang, Shiyu Xu, Huijie Guo, Li Lu, Jie Liu, Guangji Wang, Kun Hao. Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis. J Cell Mol Med 2020
    https://doi.org/10.1111/jcmm.15230